SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Morgan Stanley Maintains Equal-Weight on Prelude Therapeutics, Raises Price Target to $38

Morgan Stanley maintains Prelude Therapeutics (NASDAQ:PRLD) with a Equal-Weight and raises the price target from $34 to $38.

· 11/12/2020 08:08
Morgan Stanley maintains Prelude Therapeutics (NASDAQ:PRLD) with a Equal-Weight and raises the price target from $34 to $38.